ArcDia International Information

ArcDia International Ltd provides the most complete solutions for acute infection diagnosis with our mariPOC rapid antigen tests. Our aim is to promote healthier living and improved health care processes for respiratory and gastrointestinal infections such as COVID-19, influenza, RSV, CDI and many more. The mariPOC platform is based on antigen detection using sandwich immunoassay principle and two-photon excited fluorescence assay technique. Thanks to the unique and proprietary technology, the platform provides automation, ease-of-use, multianalyte capability, cost-efficiency and high performance. With more than 10 years of experience in the in vitro diagnostics industry, ArcDia is an ISO 13485 certified company providing our mariPOC test system for global distribution. Our high-tech Nordic diagnostic solutions are made in Turku, in the heart of Finland’s health industry. Our product portfolio also includes mariAST (RUO), a solution for tackling antibiotic resistance by speeding up antimicrobial susceptibility testing and mariCloud, an on-line service for real-time epidemiological surveillance. ArcDia envisions a healthier planet by facilitating correct diagnosis and treatment, avoiding unnecessary antibiotics and enabling a faster recovery.